Skip to main content
رجوع
Watch Compare

FibroBiologics, Inc.

جودة البيانات: 83%
FBLG
NASDAQ Manufacturing Chemicals
KWD 1.35
▼ KWD 0.06 (-4.26%)
6 months return
—
Momentum
Neutral
ROE
-3785.99%

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-3785.99%
أقل من متوسط القطاع (-54.68%)
ROIC-529.82%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio0.78
Interest Coverage-83.25

التقييم

PE (TTM|NTM)
-0.33 | -0.25
أعلى من متوسط القطاع (-1.50)
P/B Ratio49.78
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -16.66 M

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

3 محللين
Buy
+3085.2%
upside to target
الحالي
KWD 1.35
Consensus Target
KWD 43.00
KWD 19.00
أدنى
KWD 80.00
أعلى
التوقعات
مكرر الربحية المستقبلي
-0.25
ربحية السهم المستقبلية
-KWD 5.40
الإيرادات المقدّرة
0.0

مفاجآت الأرباح

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -KWD 1.40 · Rev Est: 0.0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -KWD 2.80 -KWD 2.40 -KWD 2.60 -KWD 0.60 — —
Estimate -KWD 2.50 -KWD 2.40 -KWD 2.30 -KWD 2.00 -KWD 1.40 -KWD 1.00
المفاجأة -12.00% 0.00% -13.04% +70.00% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -3785.99% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -18.65 M
ROE -3785.99% ROA -164.64%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -16.66 M
ROIC -529.82% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 0.78
Debt / Equity N/A Current Ratio 0.78
Interest Coverage -83.25 Asset Turnover N/A
Working Capital -1.48 M Tangible Book Value 125,000

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0.33 · EV/EBITDA: N/A
P/E Ratio -0.33 Forward P/E -0.25
P/B Ratio 49.78 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -267.69%
Market Cap 6.22 M Enterprise Value 1.36 M

Per Share

EPS: -0.42 · FCF/Share: -3.67
EPS (Diluted TTM) -0.42 Revenue / Share N/A
FCF / Share -3.67 OCF / Share -3.61
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 89.33% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 89.33%
SBC-Adj. FCF -19.17 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue — — —
Net Income -18.65 M -11.16 M -16.49 M
EPS (Diluted) -0.42 -0.34 -0.68
Gross Profit — — —
Operating Income -16.65 M -13.74 M -8.89 M
EBITDA — — —
R&D Expenses 7.41 M 4.50 M 2.37 M
SG&A Expenses — — —
D&A — — —
Interest Expense 200,000.0 20,000.0 147,000.0
Income Tax 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 9.62 M 16.45 M 11.82 M
Total Liabilities 3.46 M 13.71 M 10.57 M
Shareholders' Equity 6.16 M 2.74 M 1.25 M
Total Debt — 300,000.0 60,000.0
Cash & Equivalents 4.89 M 13.99 M 9.16 M
Current Assets 6.35 M 14.23 M 9.22 M
Current Liabilities 1.76 M 12.73 M 9.18 M

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1605 نظير)
المقياس السهم وسيط القطاع
P/E -0.3 -1.5
P/B 49.8 1.6
ROE % -3786.0 -54.7
Net Margin % — -41.5
Rev Growth 5Y % — 1.7
D/E — 0.3

ETFs Holding This Stock
BRSIX BRSIX
0.07% weight